Prevalence and perceptions of flavour capsule cigarettes among adults who smoke in Brazil, Japan, Republic of Korea, Malaysia and Mexico: findings from the ITC surveys
Document Type
Article
Publication Date
4-1-2024
Abstract
Introduction The global market of flavour capsule cigarettes (FCCs) has grown significantly over the past decade; however, prevalence data exist for only a few countries. This study examined prevalence and perceptions of FCCs among adults who smoke across five countries.Methods Cross-sectional data among adults who smoked cigarettes came from the International Tobacco Control Policy Evaluation Project Surveys-Brazil (2016/2017), Japan (2021), Republic of Korea (2021), Malaysia (2020) and Mexico (2021). FCCs use was measured based on reporting one's usual/current brand or favourite variety has flavour capsule(s). Perceptions of the harmfulness of one's usual brand versus other brands were compared between those who used capsules versus no capsules. Adjusted logistic regression models examined correlates of FCC use.Results There were substantial differences in the prevalence of FCC use among adults who smoke across the five countries: Mexico (50.3% in 2021), Republic of Korea (31.8% in 2021), Malaysia (26.5% in 2020), Japan (21.6% in 2021) and Brazil (6.7% in 2016/2017). Correlates of FCC use varied across countries. Capsule use was positively associated with being female in Japan and Mexico, younger age in Japan, Republic of Korea and Malaysia, high education in Brazil, Japan and Mexico, non-daily smoking in Republic of Korea, and having plans to quit in Japan and Republic of Korea. There was no consistent pattern of consumer perceptions of brand harmfulness.Conclusion Our study documented the high prevalence of FCCs in some countries, pointing to the need to develop and implement regulatory strategies to control these attractive products.
Keywords
Cross-Sectional Studies, EPIDEMIOLOGY, Health Equity, PUBLIC HEALTH
Divisions
fac_med
Funders
Institut National du Cancer (INCA) France,Brazil Fundaco do Cancer (BR/LOA/1500048.001),Pan American Health Organization (PAHO),Canadian Institutes of Health Research (CIHR) (MOP-115016) ; (FDN-148477) ; (FDN-148477),Malaysia Ministry of Higher Education LRGS NanoMITe (RU029-2014),University of Malaya Research University Grants (RU029C2014) ; (RU001A-2021),United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH Fogarty International Center (FIC) (R01 TW010652),Bloomberg Philanthropies (MEXICO-27-01),UK Research & Innovation (UKRI) Engineering & Physical Sciences Research Council (EPSRC),Ontario Institute for Cancer Research (IA-004)
Publication Title
BMJ Open
Volume
14
Issue
4
Publisher
BMJ Publishing Group
Publisher Location
BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND